Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance
in portfolio news
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced financial results for the twelve months ended December 31, 2015 and provided details on its outlook for 2016.